NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS: INTEGRATING MECHANISMS, DIAGNOSTIC ATTRIBUTION AND MANAGEMENT STRATEGIES
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4893Keywords:
Systemic Lupus Erythematosus (SLE), Neuropsychiatric Lupus (NPSLE), Autoimmunity, Neuroinflammation, Cognitive Dysfunction, Lupus PsychosisAbstract
Objective: To synthesize contemporary evidence on the pathogenesis, clinical spectrum, diagnostic challenges and therapeutic approaches in neuropsychiatric systemic lupus erythematosus (NPSLE), with particular emphasis on diffuse cognitive and psychiatric manifestations.
Methods: A narrative review was conducted using PubMed and Scopus to identify peer-reviewed studies published between 2019 and 2025. Mechanistic, clinical, neuroimaging and biomarker-focused research was included, with selective incorporation of earlier foundational work relevant to core pathogenic concepts.
Findings: Current evidence indicates that NPSLE arises from convergent mechanisms involving blood–brain barrier dysfunction, autoantibody-mediated neuronal injury, complement activation and microglial-driven synaptic loss. While focal presentations such as stroke or seizures typically reflect antiphospholipid-mediated vascular pathology, diffuse manifestations - including cognitive dysfunction, mood disorders and acute confusional states - primarily result from neuroinflammatory, excitotoxic and microglial-dependent processes. Despite progress in identifying candidate biomarkers such as anti-NR2, anti-ribosomal-P and CSF neopterin, no validated tool reliably differentiates inflammatory from non-inflammatory neuropsychiatric events. Advances in neuroimaging modalities (DTI, MRS, TSPO-PET) show promise but remain insufficiently standardized for routine clinical use. Acute inflammatory presentations may respond to high-dose glucocorticoids and immunosuppressants, however, chronic cognitive dysfunction remains largely refractory to current therapeutic strategies.
Conclusions: Although significant progress has been made in defining the immunological and neurobiological underpinnings of NPSLE, translation into precise diagnostic tools and durable treatment remains limited. The development of integrated biomarker panels, harmonized neuroimaging protocols and mechanism-based therapeutic strategies is essential to improving attribution accuracy and long-term outcomes in patients with NPSLE.
References
Fanouriakis, A., Bertsias, G., & Govoni, M. (2019). Editorial: Lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus. Frontiers in Medicine, 6, 52. https://doi.org/10.3389/fmed.2019.00052
Fanouriakis, A., Kostopoulou, M., Cheema, K., Anders, H. J., Aringer, M., Bajema, I., … Houssiau, F. A. (2024). 2023 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases, 83(1), 15–29. https://doi.org/10.1136/ard-2023-224762
Fidan, Y. S., Calli, S. Y., Sakiroglu, M. A., & Alomari, O. (2025). Diagnostic treatment dilemma in systemic lupus erythematosus presenting with psychotic symptoms: a case series. Reumatología Clínica (English Edition). https://doi.org/10.1016/j.reuma.2025.501842
Hanly, J. G. (2020). Management of neuropsychiatric lupus in the 21st century: still so many unmet needs? Rheumatology, 59(Suppl 5), v52–v62. https://doi.org/10.1093/rheumatology/keaa404
Justiz-Vaillant, A. A., Danuthia, J. P., & Ramphal, P. (2024). Autoantibodies in systemic lupus erythematosus. Molecules, 29(4), 747. https://doi.org/10.3390/molecules29040747
Kello, N., Anderson, E. W., & Diamond, B. (2019). Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials. Arthritis & Rheumatology, 71(9), 1413–1425. https://doi.org/10.1002/art.40933
Lucas-Hernández, M., Pineda-Sic, R., Islas, G., & Sobrino-Mejía, F. (2025). Catatonia as the initial manifestation of neuropsychiatric lupus. Oxford Medical Case Reports, 2025(11), 952–955. https://doi.org/10.1093/omcr/omaf249
Makowska, J., Walecka, I., Suszek, D., Roch, M., Sikorska-Szaflik, H., Bachta, A., … Samotij, D. (2025). Protocol for the development of Polish clinical guidelines for the management of patients with systemic lupus erythematosus. Reumatologia, 63(1), 35–40. https://doi.org/10.5114/reum.199640
Müller, F., Taubmann, J., Bucci, L., Kleyer, A., Völkl, S., Kist, M., … Schett, G. (2024). CD19 CAR T-cell therapy in autoimmune disease: a case series with follow-up. The New England Journal of Medicine, 390(8), 687–700. https://doi.org/10.1056/NEJMoa2308917
Nikolopoulos, D., Fanouriakis, A., Papastefanakis, E., Adamichou, C., Simopoulou, T., Klagou, A., … Bertsias, G. (2023). Cerebral small vessel disease and cognitive impairment in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 82(5), 646–655. https://doi.org/10.1136/ard-2022-223506
Sapountzi, T., Zafeiropoulou, S., Papathanasiou, M., Fellman, B., Kapoglou, P., Katsicas, M., … Bertsias, G. (2025). Biomarkers in pediatric neuropsychiatric systemic lupus erythematosus: a systematic review. Life, 15(9), 1445. https://doi.org/10.3390/life15091445
Sarwar, S. S., Mohamed, A. S., Rogers, S., Ahmed, S., Rahman, A. U., Khan, M. A., … Chaudhry, M. A. (2021). Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus, 13(9), e17969. https://doi.org/10.7759/cureus.17969
Seet, D., Allameen, N. A., Tay, S. H., Cho, J., & Mak, A. (2021). Cognitive dysfunction in systemic lupus erythematosus: immunopathology, clinical manifestations, neuroimaging and management. Rheumatology and Therapy, 8(2), 651–679. https://doi.org/10.1007/s40744-021-00312-0
Shimizu, S., & Nakamori, M. (2024). Blood–brain barrier disruption in neuroimmunological diseases. International Journal of Molecular Sciences, 25(19), 10625. https://doi.org/10.3390/ijms251910625
Su, S. T., Lin, Y. C., Chang, Y. H., Chen, M. H., Huang, Y. C., Huang, C. C., … Chou, T. M. (2025). Microglial activation and neuroinflammation in neuropsychiatric systemic lupus erythematosus. Frontiers in Immunology, 16, 1651874. https://doi.org/10.3389/fimmu.2025.1651874
Yin, R., Li, L., Xu, L., Sui, M., Guo, L., & Ye, Z. (2022). Association between depression and sleep quality in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Sleep and Breathing, 26, 429–441. https://doi.org/10.1007/s11325-021-02505-1
Zhang, L., Fu, T., Yin, R., Zhang, Q., & Shen, B. (2017). Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry, 17, 70. https://doi.org/10.1186/s12888-017-1234-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Anna Nagrodzka, Klaudia Bartela, Kamil Bronikowski, Iga Kwiecień, Karolina Bartoszewska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
